GNAQ promotes RHOA activation through ARHGEF25, which in turn regulates cellular functions by modulating cell proliferation and apoptosis, thereby influencing the progression of NKTCL. This evidence concerns the gene ARHGEF25 and extranodal nasal NK/T cell lymphoma.